UNITED THERAPEUTICS Corp (UTHR) financials

UNITED THERAPEUTICS Corp (UTHR) revenue, EBIT and EBITDA, earnings per share, free cash flow, margins, debt and shareholders equity — annual and quarterly history, charted from SEC filings. No account needed.

In fiscal 2025, UNITED THERAPEUTICS Corp reported revenue of $3.18B, up 10.6% year over year, net income of $1.33B, diluted EPS of $27.86 and free cash flow of $1.04B.

Revenue (fiscal 2025)

$3.18B

Revenue growth (fiscal 2025)

10.6%

Net income (fiscal 2025)

$1.33B

Diluted EPS (fiscal 2025)

$27.86

Free cash flow (fiscal 2025)

$1.04B

UNITED THERAPEUTICS Corp files with the U.S. Securities and Exchange Commission under CIK 0001082554, classified as Pharmaceutical Preparations.

Explore annual and quarterly revenue, earnings, cash flow, margins, debt and equity from SEC filings.